Literature DB >> 17986274

Migraine incidence, comorbidity and health resource utilization in the UK.

C Becker1, G P Brobert, P M Almqvist, S Johansson, S S Jick, C R Meier.   

Abstract

Population-based data on migraine incidence and comorbidity are scarce. We therefore aimed to quantify incidence rates and comorbidity of diagnosed migraine and health resource utilization (HRU) in migraineurs in the UK primary care setting. We conducted a follow-up study with a nested case-control analysis on the General Practice Research Database. The study encompassed 51,688 patients with a first-time diagnosis of migraine between 1994 and 2001, and the same number of matched controls. The migraine incidence rate was 3.69 (95% confidence interval 3.66, 3.73) cases per 1000 person-years. It was around 2.5 times higher in women. Most chronic diseases were slightly more prevalent in migraineurs than in controls. Triptan users had higher health resource utilization than other migraineurs. This study shows that migraine is a common diagnosis in general practice and associated with a high prevalence of comorbidity. The increased HRU in triptan users suggests greater migraine severity.

Entities:  

Mesh:

Year:  2007        PMID: 17986274     DOI: 10.1111/j.1468-2982.2007.01469.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  11 in total

1.  Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy.

Authors:  Chiara Biagi; Elisabetta Poluzzi; Giuseppe Roberto; Aurora Puccini; Alberto Vaccheri; Roberto D'Alessandro; Domenico Motola; Nicola Montanaro
Journal:  Eur J Clin Pharmacol       Date:  2011-06-15       Impact factor: 2.953

Review 2.  [Integrated headache care network. Kiel Migraine and Headache Center and German National Headache Treatment Network].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; A Göbel; A Heinze
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

3.  Secular Trends in the Incidence of Migraine in China from 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis.

Authors:  Yufeng Wang; Xueying Huang; Suru Yue; Jie Liu; Shasha Li; Huan Ma; Liren Hu; Jiayuan Wu
Journal:  J Pain Res       Date:  2022-01-14       Impact factor: 3.133

4.  Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study.

Authors:  Han Le; Peer Tfelt-Hansen; Axel Skytthe; Kirsten Ohm Kyvik; Jes Olesen
Journal:  BMJ Open       Date:  2012-07-02       Impact factor: 2.692

5.  CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships.

Authors:  Rhea Yan Ying Tan; Hugh Stephen Markus
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 6.  A critical review of manual therapy use for headache disorders: prevalence, profiles, motivations, communication and self-reported effectiveness.

Authors:  Craig S Moore; David W Sibbritt; Jon Adams
Journal:  BMC Neurol       Date:  2017-03-24       Impact factor: 2.474

7.  Associations Between Headache-Free Days and Patient-Reported Outcomes Among Migraine Patients: A Cross-Sectional Analysis of Survey Data in Europe.

Authors:  Michael J Doane; Shaloo Gupta; Pamela Vo; Annik K Laflamme; Juanzhi Fang
Journal:  Pain Ther       Date:  2019-07-26

8.  Headache, migraine and risk of brain tumors in women: prospective cohort study.

Authors:  Tobias Kurth; Julie E Buring; Pamela M Rist
Journal:  J Headache Pain       Date:  2015-03-01       Impact factor: 7.277

9.  Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey.

Authors:  Betul Baykan; Mustafa Ertas; Necdet Karlı; Derya Uluduz; Ugur Uygunoglu; Esme Ekizoglu; Elif Kocasoy Orhan; Sabahattin Saip; Mehmet Zarifoglu; Aksel Siva
Journal:  J Headache Pain       Date:  2015-12-03       Impact factor: 7.277

Review 10.  Migraine and stroke.

Authors:  Yonghua Zhang; Aasheeta Parikh; Shuo Qian
Journal:  Stroke Vasc Neurol       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.